Both in Lab Analytical Instruments
Cytek Biosciences vs Pacific Biosciences of California
Over the past year CTKB returned +70.4% and PACB returned +46.4%; their daily moves had a correlation of 0.38.
CTKB +70.4% PACB +46.4%Growth of $1, one year, split-adjusted
| Metric | CTKB | PACB |
|---|---|---|
| Price | $5.76 | $1.83 |
| Market cap | $748.7M | $568.8M |
| Today | +0.35% | +7.02% |
| 1 month | +23.1% | +30.7% |
| 6 months | +34.0% | +45.2% |
| Year to date | +14.1% | −2.1% |
| 1 year | +69.4% | +51.2% |
| Revenue growth (YoY) | +5.6% | −1.9% |
| Gross margin | 58.9% | 32.4% |
| Net margin | −25.3% | −114.7% |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | 3.6× |
| Net cash | $261.8M | -$407.5M |
| Dividend yield | — | — |
| Volatility (60d) | 44.4% | 83.2% |
| Short % of float | 4.5% | 19.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).